No Data
No Data
Context Therapeutics to Participate in Upcoming Investor Conferences in November
12 Health Care Stocks Moving In Tuesday's After-Market Session
Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
Context Networks and Aristocrat Technologies Partner on API Agreement to Enhance Player Engagement and Drive New Revenue for Gaming Operators
Context Therapeutics Management to Meet With Piper Sandler
Maxim Group Maintains Context Therapeutics(CNTX.US) With Buy Rating, Maintains Target Price $10
No Data
No Data